G
Glenn M. Chertow
Researcher at Stanford University
Publications - 830
Citations - 94517
Glenn M. Chertow is an academic researcher from Stanford University. The author has contributed to research in topics: Kidney disease & Dialysis. The author has an hindex of 128, co-authored 764 publications receiving 82401 citations. Previous affiliations of Glenn M. Chertow include University of Groningen & Fresenius Medical Care.
Papers
More filters
Journal ArticleDOI
Validation of Reported Predialysis Nephrology Care of Older Patients Initiating Dialysis
TL;DR: There is substantial disagreement between information from the CMS Medical Evidence Report and Medicare physician claims on the timing of first predialysis nephrologist care.
Journal ArticleDOI
A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function
Hiddo J.L. Heerspink,Hongzheng Yang,David Z.I. Cherney,Douwe Postmus,Bergur V. Stefánsson,Glenn M. Chertow,Jamie P. Dwyer,Tom Greene,Mikhail Kosiborod,Anna Maria Langkilde,John J.V. McMurray,Ricardo Correa-Rotter,Peter Rossing,C. David Sjöström,Robert D. Toto,David C. Wheeler,Dapa-Ckd Trial Committees,Investigators +17 more
TL;DR: In this article, a pre-specified analysis of DAPA-CKD assessed the impact of sodium-glucose cotransporter 2 inhibition on abrupt declines in kidney function in high-risk patients based on having chronic kidney disease and substantial albuminuria.
Journal ArticleDOI
Associations of Body Mass Index and Body Fat With Markers of Inflammation and Nutrition Among Patients Receiving Hemodialysis
Cynthia Delgado,Cynthia Delgado,Glenn M. Chertow,George A. Kaysen,Lorien S. Dalrymple,John Kornak,Barbara Grimes,Kirsten L. Johansen +7 more
TL;DR: Proxies of visceral and subcutaneous fat appear to have opposing associations with biomarkers of inflammation and nutrition, and the observed associations implicate visceral fat as the cause of inflammation.
Journal ArticleDOI
Low testosterone is associated with frailty, muscle wasting and physical dysfunction among men receiving hemodialysis: a longitudinal analysis.
Janet M. Chiang,George A. Kaysen,Mark R. Segal,Glenn M. Chertow,Cynthia Delgado,Cynthia Delgado,Kirsten L. Johansen,Kirsten L. Johansen +7 more
TL;DR: Serum free testosterone concentration was associated with frailty, physical function, sarcopenia and muscle mass as well as with changes in these outcomes over 12 months, and testosterone replacement may be a feasible therapeutic target toward prevention of frailty.
Journal ArticleDOI
Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINT.
Srinivasan Beddhu,Jincheng Shen,Alfred K. Cheung,Paul L. Kimmel,Glenn M. Chertow,Guo Wei,Robert E. Boucher,Michel Chonchol,Farid Arman,Ruth C. Campbell,Gabriel Contreras,Jamie P. Dwyer,Barry I. Freedman,Joachim H. Ix,Joachim H. Ix,Kent Kirchner,Vasilios Papademetriou,Roberto Pisoni,Roberto Pisoni,Michael V. Rocco,Paul K. Whelton,Tom Greene +21 more
TL;DR: There was no evidence that the reduction in eGFR owing to intensive systolic BP lowering attenuated the beneficial effects of this intervention on cardiovascular events or all-cause mortality.